Meet over 65 universities on 27 & 28 April GET YOUR FREE TICKET >
Anglia Ruskin University ARU Featured PhD Programmes
Anglia Ruskin University ARU Featured PhD Programmes

Precision Medicine - Interpretation of enhancer mutations driving cancer onset, progression, and treatment


Liggins Institute

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
Dr J O'Sullivan , Dr W Schierding No more applications being accepted Funded PhD Project (Students Worldwide)
Auckland New Zealand Bioinformatics Cell Biology Genetics Computer Science Information Services

About the Project

Every individual has an underlying genetic susceptibility for cancer development. Across all cancer types, the full complement of events driving tumour development still defies identification and, in many cases, no genetic drivers are found. Working within the internationally renowned Liggins Institute, the successful applicant will use machine learning to predict, from thousands of cancer genomes, the non-coding genomic elements driving the 38 most common cancer types. Detecting such alterations is fundamentally and technically challenging (combinatorically enormous number of ways that a genome can be altered), but our successfully established computational/bioinformatic approaches provide functional interpretation of the impact of genetic variation, genome structure, and gene expression to identify personalised risk factors. Applying our approaches across cancer types will identify new drivers of cancer susceptibility, initiation, progression, and clinical response. Our goal is to take the predictors to the clinic, translating the results into changes in clinical practice, diagnostic reports, and public policy that improve cancer treatment.

This project will be supervised by Associate Professor Justin M. O’Sullivan and Dr William Schierding (Liggins Institute, the University of Auckland, New Zealand), and collaborate with Professor Cristin Print (Genetics into Medicine) and Dr Jo Perry (Liggins Institute) as part of a very productive and supportive international research team.

Objective

1.  Identify potential non-coding mutations that can act as drivers influencing cancer susceptibility, initiation, progression, and clinical response

2.  Extend previously developed computational approaches (machine learning) to predict, from thousands of cancer genomes, which non-coding genomic elements drive the 38 most common cancer types

3.  From those driver mutations, provide a functional interpretation of the impact of genetic variation, genome structure, and gene expression to identify personalised risk factors across cancer types

4.  Translate the new molecular understanding into risk prediction (diagnostic reports) that can be used in clinical practice across several NZ-based cancer studies

What we are looking for in a successful applicant

Applicants should have a demonstrated background in genetics, bioinformatics, computational biology, or related subjects. Applicants must fulfil all conditions for admission to the doctoral programme at the University of Auckland. These can be found here: https://www.auckland.ac.nz/en/study/applications-and-admissions/entry-requirements/postgraduate-entry-requirements/doctoral-entry-requirements.html


Funding Notes

Requests for further information and applications for positions should be sent to [Email Address Removed]. Applications should include a full CV, an academic transcript, and a cover letter outlining your interests in relation to our research. Applications will close once a suitable applicant has been identified, so please submit your application soon.
Search Suggestions

Search Suggestions

Based on your current searches we recommend the following search filters.



FindAPhD. Copyright 2005-2021
All rights reserved.